Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: Role of confounding and reference group

Atherosclerosis

Volumn 170, Issue 2, 2003, Pages 339-345

  Rothenbacher, Dietrich ^a   Brenner, Hermann ^a   Hoffmeister, Albrecht ^b   Mertens, Thomas ^c   Persson, Kenneth ^d   Koenig, Wolfgang ^b  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Case control study; Coronary artery disease; Inflammation; Multiple infections; Seropositivity

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; IMMUNOGLOBULIN G; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CELL COUNT; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CHLAMYDIA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATIENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0242409595     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00300-9     Document Type: Article

References (36)

1. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc. 279:1998;1477-1482.
2. Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J. 19(Suppl C):1998;C39-C43.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126.
4. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
5. Whincup P.H., Mendall M.A., Perry I.J., Strachan D.P., Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart. 75:1996;568-572.
6. Strandberg T.E., Tilvis R.S., Vuoristo M., Lindroos M., Kosunen T.U. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ. 314:1997;317-318.
7. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 315:1997;1199-1201.
8. Folsom A.R., Nieto J.F., Sorlie P., Chambless L.E., Graham D.Y. Helicobacter pylori seropositivity and coronary heart disease incidence: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 98:1998;845-850.
9. Strachan D.P., Mendall M.A., Carrington D., Butland B.K., Yarnell J.W., Sweetnam P.M.et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation. 98:1998;1286-1290.
10. Ridker P.M., Hennekens C.H., Burin J.E., Kundsin R., Shih J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med. 131:1999;573-575.
11. Roivainen M., Viik-Kajander M., Palosuo T.P., Leinonen M., Saikku P., Tenkanen L.et al. Infections, inflammation, and the risk of coronary heart disease. Circulation. 101:2000;252-257.
12. Whincup P., Danesh J., Walker M., Lennon L., Thomson A., Appleby P.et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation. 101:2000;1647-1652.
13. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ. 321:2000;208-213.
14. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J. 138:1999;S434-S437.
15. Brenner H., Berg G., Fröhlich M., Boeing H., Koenig W. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study. Atherosclerosis. 147:1999;399-403.
16. Epstein S.E., Zhou J., Burnett M.S., Zhou Y.F., Vercellotti G., Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 20:2000;1417-1420.
17. Brade L., Brunnemann H., Ernst M., Fu Y., Holst O., Kosma P.et al. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol Med Microbiol. 8:1994;27-41.
18. Brade L., Holst O., Kosma P., Zhang X.Y., Paulsen H., Krausse R.et al. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide. Infect Immunol. 58:1990;205-213.
19. Hoffmeister A., Rothenbacher D., Wanner P., Bode G., Persson K., Brenner H.et al. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case-control study. J Am Coll Cardiol. 35:2000;112-118.
20. Hutchinson W.L., Koenig W., Fröhlich M., Sund M., Lowe G.D., Pepys M.B. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem. 46:2000;934-938.
21. SAS Language: Reference 6, first ed. Cary (North Carolina): SAS Institute, Inc.; 1990.
22. Zhu J., Quyyumi A.A., Norman J.E., Csako G., Waclawiw M.A., Shearer G.M.et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 85:2000;140-146.
23. Rupprecht H.J., Blankenberg S., Bickel C., Rippin G., Hafner G., Prellwitz W.et al. AutoGene Investigators: impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 104:2001;25-31.
24. Zhu J., Nieto J., Horne B.D., Anderson J.L., Muhlestein J.B., Epstein S.E. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 103:2001;45-51.
25. Anderson J.L., Carlquist J.F., Muhlestein J.B., Horne B.D., Elmer S.P. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 32:1998;35-41.
26. DeBaker J., Mak R., De Bacquer D., Van Renterghem L., Verbraekel E., Kornitzer M.et al. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis. 160:2002;457-464.
27. Haider A.W., Wilson P.W.F., Larson M.G., Evans J.C., Michelson E.L., Wolf P.A.et al. The association of seropositivity to Helicobacter Pylori, Chlamydia Pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol. 40:2002;1408-1413.
28. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 96:1997;4095-4103.
29. Mehta J.L., Saldeen T.G.P., Rand K. Interactive role of infection inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol. 31:1998;1217-1225.
30. Koenig W. Heart disease and the inflammatory response. BMJ. 321:2000;187-188.
31. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P.et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 321:2000;199-204.
32. Ridker P.M., Kundsin R.B., Stampfer M.J., Poulin S., Hennekens C.H. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 99:1999;1161-1164.
33. Ridker P.M., Hennekens C.H., Stampfer M.J., Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 98:1998;2796-2799.
34. Ericson K., Saldeen T.G.P., Lindquist O., Pahlson C., Mehta J.L. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation. 101:2000;2568-2571.
35. Davidson M., Kuo C.C., Middaugh J.P., Campbell L.A., Wang S.P., Newman W.P. 3rdet al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 98:1998;628-633.
36. Parmley W.W. Prevalence and clinical significance of silent myocardial ischemia. Circulation. 80(Suppl IV):1989;68-73.